Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.11.2023 | Case report

Atovaquone

Lack of efficay

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Dieringer TD, et al. Application of Targeted Next Generation Sequencing for Early Diagnosis of Donor-Derived Toxoplasma Gondii in a Heart Transplant Patient. American Journal of Transplantation 23 (Suppl. 1): S939 abstr. C-72, No. 6, Jun 2023. Available from: URL: https://dx.doi.org/10.1016/j.ajt.2023.05.014 [abstract] Dieringer TD, et al. Application of Targeted Next Generation Sequencing for Early Diagnosis of Donor-Derived Toxoplasma Gondii in a Heart Transplant Patient. American Journal of Transplantation 23 (Suppl. 1): S939 abstr. C-72, No. 6, Jun 2023. Available from: URL: https://​dx.​doi.​org/​10.​1016/​j.​ajt.​2023.​05.​014 [abstract]
Metadaten
Titel
Atovaquone
Lack of efficay
Publikationsdatum
01.11.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-49430-x

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Furosemide

Case report

Multiple drugs

Case report

Bortezomib

Case report

Azvudine

Case report

Ipilimumab

Case report

Zolpidem